Skip to main content
Clinical Trials/NCT02395874
NCT02395874
Unknown
Not Applicable

MP-LoGa: Bi-hemispheral Transcranial Direct Current Stimulation to Improve the Severe Aphasia in Subacute Stroke Patients: a Randomized, Placebo-controlled, Double Blinded Multi-center Trial

Medical Park AG1 site in 1 country96 target enrollmentMay 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Aphasia, Global
Sponsor
Medical Park AG
Enrollment
96
Locations
1
Primary Endpoint
Goodglass-Kaplan communication scale (GKS, 0-5)
Last Updated
9 years ago

Overview

Brief Summary

To study the effect of combined tDCS plus speech therapy compared to sham-tDCS plus speech therapy in subacute stroke patients suffering from moderate or severe aphasia. The patients will be randomized by a computer-generated lot. Assessment will be performed at study onset, after six weeks at the end of the specific intervention and 4 months after stroke onset for follow-up.

Detailed Description

Approximately 25% of all patients after stroke suffer from aphasia. The aphasia could be so severe, that the patient cannot produce any words at all, and so the communication ability is rather poor. In that case speech therapy is the most common therapy, but the functional outcome for the patient is often not sufficiently. The transcranial direct current stimulation (tDCS) might improve the outcome of speech therapy in patients with severe aphasia. The patients will be randomized either to verum stimulation (group A) or sham stimulation (group B). In group A they will receive every workday for 6 weeks 20min of tDCS with 2 mA in combination with a 30 min speech therapy. In group B they will receive every workday for 6 weeks 20min of tDCS with 0 mA in combination with a 30 min speech therapy. The anodal electrode will be placed in case of a total anterior circulation stroke on the homologous speech area on the right hemisphere and in case of a partial anterior circulation stroke perilesional on the left hemisphere. The cathode will be positioned contralateral.

Registry
clinicaltrials.gov
Start Date
May 2015
End Date
October 2018
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Medical Park AG
Responsible Party
Principal Investigator
Principal Investigator

Cordula Werner

Head of Research Lab

Medical Park AG

Eligibility Criteria

Inclusion Criteria

  • first time stroke (ischemic or hemorrhagic), either with a total or partial anterior circulation stroke according to the Bamford classification
  • stroke interval 10-45 days
  • moderate or severe aphasia, i.e. Goodglass-Kaplan-Communication-Scale (GKS, 0,1 or 2)
  • native speaker - german
  • age 18-90

Exclusion Criteria

  • other neurological diseases affecting the CNS
  • known history of epileptic fits, except for an immediate fit
  • signs in the EEG of increased cortical excitability
  • patients with hemicraniectomy
  • fluent aphasia, i.e. GKS 3,4 or 5
  • speech apraxia
  • reduced sensibility of the scalp
  • previously radiated scalp
  • metallic parts or implants in the brain
  • participation in other interventional studies

Outcomes

Primary Outcomes

Goodglass-Kaplan communication scale (GKS, 0-5)

Time Frame: 10-15 min

the GKS is an ordinal scale, which assesses the communication ability of the patient from 0 to 5.

Aphasia Check-list (ACL, 0-148)

Time Frame: 30-45 min

a german tool to assess language (analogous to the Aachener Aphasie Test). it measures a) colour-figure test, b) word generation and c) single speech domains

Secondary Outcomes

  • Aphasic depression rating scale (ADRS, 0-32)(5 min)
  • Barthel-Index (BI,0-100)(5min)
  • Alterskonzentrationstest (AKT, 0-35)(5 min)
  • Rivermead Motor Assessment - Arm (RMA, 0-15)(5-10 min)

Study Sites (1)

Loading locations...

Similar Trials